Brief: Anebulo Pharma Reports Q1 2022 Financial Results

Anebulo Pharmaceuticals

12/11/2021 14:22

Nov 12 (Reuters) - Anebulo Pharmaceuticals Inc  ANEB.O :
    * ANEBULO PHARMACEUTICALS REPORTS FIRST QUARTER FISCAL YEAR
2022
FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE
    * Q1 LOSS PER SHARE $0.07
    * EXPECTS TOPLINE RESULTS TO BE AVAILABLE IN FIRST HALF OF
2022
FOR ANEB-001

Source text for Eikon:  ID:nBw9Qtz3Va 
Further company coverage:  ANEB.O 

 ((Reuters.Briefs@thomsonreuters.com;))